EKF Diagnostics
EKF.LPrivate Company
Funding information not available
Overview
EKF Diagnostics Holdings plc is a mission-driven, AIM-listed company focused on improving global healthcare through accessible, rapid diagnostic solutions and high-quality life science components. The company has established a mature, dual-pillar business model combining proprietary POC device sales with a robust contract manufacturing and reagent supply division for the biotech and pharma industries. Its strategy is built on geographic expansion, digital connectivity via its EKF Link platform, and continuous portfolio diversification across clinical and non-clinical markets, supported by a resilient global supply chain.
Technology Platform
Integrated expertise across photometric, electrochemical biosensor, and immunoassay (RaPET®) technologies for POC diagnostics, combined with precision fermentation for enzyme production and the EKF Link digital connectivity suite.
Opportunities
Risk Factors
Competitive Landscape
EKF competes with large IVD players like Abbott, Roche, and Quest (HemoCue) in POC segments, and with life science giants like Merck and Thermo Fisher in reagents. Its advantages are cost-effectiveness, vertical integration in enzymes, and its EKF Link digital ecosystem.